Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

NT-proBNP as a means of triage for the risk of hospitalisation in primary care.

Adlbrecht C, Neuhold S, Hülsmann M, Strunk G, Ehmsen U, Scholten C, Maurer G, Pacher R.

Eur J Prev Cardiol. 2012 Feb;19(1):55-61. doi: 10.1177/1741826710391545. Epub 2011 Feb 18.

PMID:
21450621
2.

N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.

Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR.

J Hypertens. 2006 Aug;24(8):1531-9.

PMID:
16877955
3.

The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.

Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.

Anesth Analg. 2009 Nov;109(5):1403-8. doi: 10.1213/ANE.0b013e3181b893dd.

PMID:
19843778
5.

NT-proBNP and cardiac events in older diabetic patients.

Resl M, Neuhold S, Riedl M, Abrahamian H, Strunk G, Prager R, Clodi M, Hülsmann M, Luger A, Pacher R.

Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):399-405. doi: 10.1177/1741826710389362. Epub 2011 Feb 22.

PMID:
21450658
6.

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.

Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL.

Eur Heart J. 2009 May;30(9):1057-65. doi: 10.1093/eurheartj/ehn600. Epub 2009 Jan 23.

PMID:
19168526
7.

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.

Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048. Epub 2008 Jul 9.

PMID:
18773998
8.

Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.

van Hateren KJ, Alkhalaf A, Kleefstra N, Groenier KH, de Jong PE, de Zeeuw D, Gans RO, Struck J, Bilo HJ, Gansevoort RT, Bakker SJ.

Clin Chem. 2012 Jan;58(1):293-7. doi: 10.1373/clinchem.2011.166348. Epub 2011 Sep 26.

9.

Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization.

Bettencourt P, Azevedo A, Fonseca L, Araújo JP, Ferreira S, Almeida R, Rocha-Goncalves F, Ferreira A.

Int J Cardiol. 2007 Apr 12;117(1):75-9. Epub 2006 Jul 14.

PMID:
16843555
10.

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN; Val-HeFT Investigators.

Clin Chem. 2006 Aug;52(8):1528-38. Epub 2006 Jun 15.

11.

Prognostic threshold levels of NT-proBNP testing in primary care.

Rosenberg J, Schou M, Gustafsson F, Badskjaer J, Hildebrandt P.

Eur Heart J. 2009 Jan;30(1):66-73. doi: 10.1093/eurheartj/ehn525. Epub 2008 Nov 23.

PMID:
19029123
12.

Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study.

Mohammed AA, van Kimmenade RR, Richards M, Bayes-Genis A, Pinto Y, Moore SA, Januzzi JL Jr.

Circ Heart Fail. 2010 May;3(3):354-61. doi: 10.1161/CIRCHEARTFAILURE.109.915280. Epub 2010 Mar 23.

13.

Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.

Eggers KM, Venge P, Lind L.

Am J Cardiol. 2013 Jan 1;111(1):131-6. doi: 10.1016/j.amjcard.2012.08.058. Epub 2012 Oct 2.

PMID:
23040598
14.

NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus.

Huelsmann M, Neuhold S, Strunk G, Moertl D, Berger R, Prager R, Abrahamian H, Riedl M, Pacher R, Luger A, Clodi M.

Eur Heart J. 2008 Sep;29(18):2259-64. doi: 10.1093/eurheartj/ehn334. Epub 2008 Jul 23.

PMID:
18650200
15.

Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.

Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.

Coron Artery Dis. 2009 May;20(3):219-24. doi: 10.1097/MCA.0b013e3283219e47.

PMID:
19322079
16.

N-terminal pro-B-type natriuretic peptide concentrations predict the risk of cardiovascular adverse events from antiinflammatory drugs: a pilot trial.

Brune K, Katus HA, Moecks J, Spanuth E, Jaffe AS, Giannitsis E.

Clin Chem. 2008 Jul;54(7):1149-57. doi: 10.1373/clinchem.2007.097428. Epub 2008 May 1.

17.

N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.

Haaf P, Balmelli C, Reichlin T, Twerenbold R, Reiter M, Meissner J, Schaub N, Stelzig C, Freese M, Paniz P, Meune C, Drexler B, Freidank H, Winkler K, Hochholzer W, Mueller C.

Am J Med. 2011 Aug;124(8):731-9. doi: 10.1016/j.amjmed.2011.02.035.

PMID:
21787902
18.

Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width.

Goode KM, Clark AL, Cleland JG.

Int J Cardiol. 2008 Nov 28;130(3):426-37. doi: 10.1016/j.ijcard.2007.08.131. Epub 2008 Feb 21.

PMID:
18178273
19.

Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.

Tziakas DN, Chalikias GK, Stakos D, Chatzikyriakou SV, Papazoglou D, Mitrousi K, Lantzouraki A, Thomaidi A, Boudoulas H, Konstantinides S.

Eur J Prev Cardiol. 2012 Feb;19(1):62-71. doi: 10.1097/HJR.0b013e32833ace76. Epub 2011 Jan 28.

PMID:
20479644
20.

N-terminal pro brain natriuretic peptide in the management of patients in the medical emergency department (PROMPT): correlation with disease severity, utilization of hospital resources, and prognosis in a large, prospective, randomized multicentre trial.

Luchner A, Möckel M, Spanuth E, Möcks J, Peetz D, Baum H, Spes C, Wrede CE, Vollert J, Müller R, Katus H, Giannitsis E.

Eur J Heart Fail. 2012 Mar;14(3):259-67. doi: 10.1093/eurjhf/hfr171. Epub 2012 Jan 20.

Supplemental Content

Support Center